Skip Nav Destination
Discovery and Characterization of a Novel Aryl Hydrocarbon Receptor Inhibitor, IK-175, and Its Inhibitory Activity on Tumor Immune Suppression
Mol Cancer Ther (2022) 21 (8): 1261–1272.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Adonis Sfera
Reports (2023) 6 (3): 36.
- Gary H. Perdew
- Charlotte Esser
- Megan Snyder
- David H. Sherr
- Ellen H. van den Bogaard
- Karen McGovern
- Pedro M. Fernández-Salguero
- Xavier Coumoul
- Andrew D. Patterson
International Journal of Molecular Sciences (2023) 24 (6): 5550.
- Jed de Ruiter Swain
- Evdokia Michalopoulou
- Evan K. Noch
- Michael J. Lukey
- Linda Van Aelst
Genes & Development (2023) 37 (15-16): 681.
- Su-Kil Seo
- Byungsuk Kwon
Experimental & Molecular Medicine (2023) 55 (7): 1371.
- Christina Kober
- Julian Roewe
- Norbert Schmees
- Lars Roese
- Ulrike Roehn
- Benjamin Bader
- Detlef Stoeckigt
- Florian Prinz
- Mátyás Gorjánácz
- Helge Gottfried Roider
- Catherine Olesch
- Gabriele Leder
- Horst Irlbacher
- Ralf Lesche
- Julien Lefranc
- Mine Oezcan-Wahlbrink
- Ankita Sati Batra
- Nirmeen Elmadany
- Rafael Carretero
- Katharina Sahm
- Iris Oezen
- Frederik Cichon
- Daniel Baumann
- Ahmed Sadik
- Christiane A Opitz
- Hilmar Weinmann
- Ingo V Hartung
- Bertolt Kreft
- Rienk Offringa
- Michael Platten
- Ilona Gutcher
Journal for ImmunoTherapy of Cancer (2023) 11 (11): e007495.
- Yinrong Wu
- Zichao Yang
- Kui Cheng
- Huichang Bi
- Jianjun Chen
Acta Pharmaceutica Sinica B (2022) 12 (12): 4287.
